
Lira Clinical Announces New REGEN Line — A First-of-Its-Kind Breakthrough in Regenerative Skincare
26.10.2026 20:33:00 CET | GlobeNewswire by notified | Press release
LIVERMORE, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lira Clinical, a global leader in corrective and brightening skincare, is proud to announce the launch of its groundbreaking new REGEN line. REGEN is the first and only clinical skincare line formulated with Wild Salmon Stem Cell–Conditioned Media — a revolutionary ingredient that delivers more regenerative power than PDRN alone.
Developed in collaboration with Wildtype, the REGEN line is a major breakthrough in PROAging skincare and the emerging category of Clinical Brightening. The REGEN line’s exclusive combination of Wild Salmon Stem Cell-CM (aka Marine Cellular Complex), PDRN, and Copper Tripeptide-1 promotes healthier, brighter skin from the inside out by supporting the key drivers of skin health: hydration, circulation, and firmness.
REGEN’s unique benefits are delivered deep into the skin by Lira Clinical’s proprietary EXO-tech™ phospholipid encapsulation technology, which carries active ingredients through the acid mantle without compromising their efficacy or damaging the skin’s protective barrier.
Wild Salmon Stem Cell–CM: A Full-Spectrum Regenerative Approach to Skincare
Wild Salmon Stem Cell–Conditioned Media, aka Marine Cellular Complex (MCC), is a next-generation regenerative complex containing nearly 2,000 different bioactive growth factors, salmon-derived exosomes, thousands of peptides, antioxidants, and stem cells that promote collagen repair and structural support while visibly reducing redness and inflammation.
Lira Clinical’s REGEN Line is the first to introduce this innovation and its benefits to the global aesthetic market.
“Lira Clinical’s core values have always been about real people, real results, with more clinical studies to come. PDRN is a buzzword now, but Lira is the first company to introduce wild salmon stem cell–conditioned media that now goes beyond the benefits of PDRN. We were able to formulate both a serum and a creme for in-clinic and home treatments.”
Metaxia Dalikas, co-founder and CEO, Lira Clinical
The REGEN Line
Lira Clinical’s REGEN line is available in two formats:
REGEN PDRN+ Serum - the first and only serum in the clinical market to combine Wild Salmon Stem Cell–CM with PDRN and Copper Tripeptide-1, delivering more regenerative power than PDRN alone to rebuild skin from within
REGEN PDRN+ Crème - a volumizing formulation that restores skin density, improves structure, and extends Clinical Brightening benefits by improving hydration, circulation, and firmness
Availability
The REGEN line is available through Lira Clinical's professional channels and international distributors worldwide.
Clinical Brightening: Beyond Surface Correction
Unlike traditional brightening skincare that corrects dark spots and dull, uneven, tired-looking skin at the surface, Clinical Brightening addresses their underlying causes, supporting the skin’s natural renewal process to improve hydration, circulation, and firmness. The result is skin that immediately looks brighter, smoother, healthier, and more alive.
Lira Clinical Skincare: Real People. Real Results.
A global leader at the forefront of skincare innovation, Lira Clinical was founded by four renowned skincare professionals dedicated to providing real results for real people, in the form of brighter, healthier, younger-looking skin. Lira Clinical’s core philosophy, Science Discovering Nature’s Secrets, reflects the company’s deep understanding of how modern biotechnology can unlock the regenerative potential found in nature to treat skin conditions and improve skin health.
Wildtype: Defending the Earth’s Wild Places
Wildtype, the San Francisco–based cultivated seafood company, is now expanding into skincare with its Marine Cellular Complex (MCC), a novel, animal-free, ocean-positive skincare science product.
Marine Cellular Complex is made from 15,540 peptides and 5,105 proteins grown from salmon cells, not actual salmon. The process is animal-free and ocean-positive, meaning it doesn’t harm wild fish populations. The complex contains a rich blend of proteins, lipids, antioxidants, salmon-derived exosomes, collagen, elastin, and other bioactive molecules that are known for their skin-benefiting properties.
Media Inquiries
Francine Kagarakis
Co-founder and CIO of Lira Clinical
francine@liraclinical.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/61eab243-fc42-43d7-a84f-660369223922
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Iveco Group signs a 150 million euro term loan facility with Cassa Depositi e Prestiti to support investments in research, development and innovation11.6.2024 12:00:00 CEST | Press release
Turin, 11th June 2024. Iveco Group N.V. (EXM: IVG), a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain and related Financial Services arenas, has successfully signed a term loan facility of 150 million euros with Cassa Depositi e Prestiti (CDP), for the creation of new projects in Italy dedicated to research, development and innovation. In detail, through the resources made available by CDP, Iveco Group will develop innovative technologies and architectures in the field of electric propulsion and further develop solutions for autonomous driving, digitalisation and vehicle connectivity aimed at increasing efficiency, safety, driving comfort and productivity. The financed investments, which will have a 5-year amortising profile, will be made by Iveco Group in Italy by the end of 2025. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a
DSV, 1115 - SHARE BUYBACK IN DSV A/S11.6.2024 11:22:17 CEST | Press release
Company Announcement No. 1115 On 24 April 2024, we initiated a share buyback programme, as described in Company Announcement No. 1104. According to the programme, the company will in the period from 24 April 2024 until 23 July 2024 purchase own shares up to a maximum value of DKK 1,000 million, and no more than 1,700,000 shares, corresponding to 0.79% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Trading dayNumber of shares bought backAverage transaction priceAmount DKKAccumulated trading for days 1-25478,1001,023.01489,100,86026:3 June 20247,0001,050.597,354,13027:4 June 20245,0001,055.705,278,50028:6 June20243,0001,096.273,288,81029:7 June 20244,0001,106.174,424,68
Landsbankinn hf.: Offering of covered bonds11.6.2024 11:16:36 CEST | Press release
Landsbankinn will offer covered bonds for sale via auction held on Thursday 13 June at 15:00. An inflation-linked series, LBANK CBI 30, will be offered for sale. In connection with the auction, a covered bond exchange offering will take place, where holders of the inflation-linked series LBANK CBI 24 can sell the covered bonds in the series against covered bonds bought in the above-mentioned auction. The clean price of the bonds is predefined at 99,594. Expected settlement date is 20 June 2024. Covered bonds issued by Landsbankinn are rated A+ with stable outlook by S&P Global Ratings. Landsbankinn Capital Markets will manage the auction. For further information, please call +354 410 7330 or email verdbrefamidlun@landsbankinn.is.
Relay42 unlocks customer intelligence with a new insights and reporting module, powered by Amazon QuickSight11.6.2024 11:00:00 CEST | Press release
AMSTERDAM, June 11, 2024 (GLOBE NEWSWIRE) -- Relay42, a leading European Customer Data Platform (CDP), is leveraging Amazon QuickSight to power its new real-time customer intelligence, reporting, and dashboard module. Harnessing the breadth and quality of customer data, the new Insights module empowers marketing teams to dive deep into customer behaviors and gain invaluable insights into the performance of their marketing programs across all online, offline, paid, and owned marketing channels. Preview of the Relay42 Insights module, in pre-beta version Key capabilities of the Relay42 Insights module include: Deep insights into customer behaviors: With the Relay42 Insights module, marketers can ask unlimited questions about their data and gain a deeper understanding of how to serve their customers more effectively. Simplicity with AI-powered querying: Marketers can use artificial intelligence to query their data using natural language search, reducing the reliance on data scientists. Us
Metasphere Labs Announces X Spaces Event on the Topic of Green Bitcoin Mining and Sound Money for Sustainability11.6.2024 10:30:00 CEST | Press release
VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere Labs" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is thrilled to announce an engaging Twitter Spaces event on Green Bitcoin mining, energy markets, and sustainability on July 3, 2024 at 2 p.m. ET. Follow us on X at MetasphereLabs for updates and to join the event. What We'll Discuss Bitcoin Mining Basics: Understand the fundamentals of Bitcoin mining. Energy Market Dynamics: Explore how Bitcoin mining interacts with energy markets. Sustainable Innovations: Learn about our efforts to promote sustainability in Bitcoin mining. Sound Money: Discover how tamper-proof currency can enhance stability. Efficient Payment Rails: See how fast, neutral payment systems support humanitarian projects. Carbon Footprint: Compare Bitcoin's environmental impact with traditional banking. "We're excited to host this event and dive into the critical topics of Bi